Prof. Dr. Markus Neurath

Lehrstuhl für Innere Medizin I (Medizin 1)

Risankizumab in patients with moderate to severe Crohn's disease: an open-label extension study (2018) Feagan BG, Panes J, Ferrante M, Kaser A, D'Haens GR, Sandborn WJ, Louis E, et al. Journal article Mechanisms of molecular resistance and predictors of response to biological therapy in inflammatory bowel disease (2018) Atreya R, Neurath M Journal article, Review article What rheumatologists can learn from gastroenterologists (2018) Fischer S, Beyer C, Neurath M Journal article Inflammatory bowel diseases : Crohn's disease and ulcerative colitis (2018) Fischer S, Rath T, Neurath M Journal article Whole-Body Electromyostimulation combined with personalized Nutritional Support improves the Body Composition of Patients with advanced Cancer (2018) Schink K, Herrmann HJ, Schwappacher R, Orlemann T, Meyer J, Waldmann E, Wullich B, et al. Conference contribution Whole-Body Electrostimulation in Combination with protein-rich Nutrition in Patients with metastatic or advanced Stage gynecological Cancer: An innovative Therapy Concept (2018) Zopf Y, Herrmann HJ, Neurath M, Reljic D Conference contribution Thiopurines in Inflammatory Bowel Disease: New Findings and Perspectives (2018) De Boer NKH, Peyrin-Biroulet L, Jharap B, Sanderson JD, Meijer B, Atreya I, Barclay ML, et al. Journal article Similar Inhibition of Dynamic Adhesion of Lymphocytes From IBD Patients to MAdCAM-1 by Vedolizumab and Etrolizumab-s (2018) Binder MT, Becker E, Wiendl M, Schleier L, Fuchs F, Leppkes M, Atreya R, et al. Journal article Treatment Perspectives in Crohn's Disease (2018) Vetter M, Neurath M Journal article The importance of pancreatic inflammation in endosonographic diagnostics of solid pancreatic masses (2018) Vitali F, Strobel D, Frulloni L, Heinrich MC, Pfeifer L, Görtz R, Hundorfean G, et al. Journal article